Functional coupling expression of COX-2 and cPLA2 induced by ATP in rat vascular smooth muscle cells: Role of ERK1/2, p38 MAPK, and NF-κB

Cardiovascular Research

Volumn 82, Issue 3, 2009, Pages 522-531

  Lin, Chih Chung ^a   Lin, Wei Ning ^a   Wang, Wei Jung ^a   Sun, Chi Chin ^b   Tung, Wei Hsuan ^a   Wang, Hui Hsin ^a   Yang, Chuen Mao ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

ATP S; COX 2; CPLA2; NF B; Vascular smooth muscle cells

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; ADENOSINE TRIPHOSPHATE; CELECOXIB; CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE A2; HELENALIN; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ADENOSINE TRIPHOSPHATE; ANIMALS; AUTOCRINE COMMUNICATION; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASES A2, CYTOSOLIC; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 66249130642     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp069     Document Type: Article

References (51)

1. 2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1beta. FASEB J 2006;20: 1727-1729.
2. Ali K, Lund-Katz S, Lawson J, Phillips MC, Rader DJ. Structure-function properties of the apoE-dependent COX-2 pathway in vascular smooth muscle cells. Atherosclerosis 2008;196:201-209.
3. Martinez-Gonzalez J, Escudero I, Badimon L Simvastatin potentiates PGI2 release induced by HDL in human VSMC: effect on Cox-2 up-regulation and MAPK signalling pathways activated by HDL. Atherosclerosis 2004;174:305-313.
4. 2 phosphorylation at S515 and S505 is required for arachidonic acid release in vascular smooth muscle cell. J Lipid Res 2008;49:724-737.
5. 2 mediate IL-1β-induced cAMP production in human vascular smooth muscle cells. Am J Physiol 1999;276:H1369-H1378.
6. Appleby SB, Ristimaki A, Neilson K, Narko K, Hla T. Structure of the human cyclo-oxygenase-2 gene. Biochem J 1994;302:723-727.
7. 2 gene. Biochem Biophys Res Commun 1994;205:6-11.
8. 2 by IL-1 b in A549 cells. Adv Exp Med Biol 1997;407:249-253.
9. 2, COX2, and lipocortin 1 expression by IL-1β in A549 cells. Biochem Biophys Res Commun 1996;220:491-495.
10. 2 in prostate carcinoma cells. Carcinogenesis 2005;26:1520-1526.
11. Di VF, Solini A. P2 receptors: new potential players in atherosclerosis. Br J Pharmacol 2002;135:831-842.
12. Laubinger W, Tulapurkar ME, Schafer R, Reiser G. Distinct mono- and dinucleotide-specific P2Y receptors in A549 lung epithelial cells: different control of arachidonic acid release and nitric oxide synthase expression. Eur J Pharmacol 2006;543:1-7.
13. 2 production in human A549 alveolar type II epithelial cells. Eur J Pharmacol 2007;566:167-171.
14. Chen WC, Chen CC. ATP-induced arachidonic acid release in cultured astrocytes is mediated by Gi protein coupled P2Y1 and P2Y2 receptors. Glia 1998;22:360-370.
15. 2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents. Prostaglandins Leukot Essent Fatty Acids 2003;69:437-448.
16. 7. J Leukoc Biol 2002;72:222-232.
17. Tran MD, Neary JT. Purinergic signaling induces thrombospondin-1 expression in astrocytes. Proc Natl Acad Sci USA 2006;103:9321- 9326.
18. Pfeiffer ZA, Guerra AN, Hill LM, Gavala ML, Prabhu U, Aga M et al. Nucleotide receptor signaling in murine macrophages is linked to reactive oxygen species generation. Free Radic Biol Med 2007;42:1506-1516.
19. LeeYJ, Han HJ. Effect of adenosine triphosphate in renal ischemic injury: involvement of NF-κB. J Cell Physiol 2005;204:792-799.
20. Korcok J, Raimundo LN, Du X, Sims SM, Dixon SJ. P2Y6 nucleotide receptors activate NF-κB and increase survival of osteoclasts. J Biol Chem 2005;280:16909-16915.
21. Korcok J, Raimundo LN, Ke HZ, Sims SM, Dixon SJ. Extracellular nucleotides act through P2X7 receptors to activate NF-κB in osteoclasts. J Bone Miner Res 2004;19:642-651.
22. Hsieh HL, Wu CB, Sun CC, Liao CH, Lau YT, Yang CM. Sphingosine-1- phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells. J Cell Physiol 2006;207: 757-766.
23. Yang L, Cranson D, Trinkaus-Randall V. Cellular injury induces activation of MAPK via P2Y receptors. J Cell Biochem 2004;91:938-950.
24. Yin J, Xu K, Zhang J, Kumar A, Yu FS. Wound-induced ATP release and EGF receptor activation in epithelial cells. J Cell Sci 2007;120:815- 825.
25. Siegfried JM, Gubish CT, Rothstein ME, Queiroz de Oliveira PE, Stabile LP. Signaling pathways involved in cyclooxygenase-2 induction by hepatocyte growth factor in non small-cell lung cancer. Mol Pharmacol 2007;72: 769-779.
26. Nieminen R, Lahti A, Jalonen U, Kankaanranta H, Moilanen E. JNK inhibitor SP600125 reduces COX-2 expression by attenuating mRNA in activated murine J774 macrophages. Int Immunopharmacol 2006;6:987-996.
27. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 1998;273:18623-18632.
28. Singh RP, Dhawan P, Golden C, Kapoor GS, Mehta KD. One-way cross-talk between p38(MAPK) and p42/44(MAPK). Inhibition of p38(MAPK) induces low density lipoprotein receptor expression through activation of the p42/44(MAPK) cascade. J Biol Chem 1999;274: 19593-19600.
29. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 2001 ;98:13681 -13686.
30. Bren-Mattison Y, Meyer AM, Van Putten V, Li H, Kuhn K, Stearman R et al. Antitumorigenic effects of peroxisome proliferator-activated receptor-γ in non-small cell lung cancer cells are mediated by suppression of COX-2 via inhibition of NF-κB. Mol Pharmacol 2008;78:709-717.
31. Li Q, Guo Y, Tan W, Ou Q, Wu WJ, Sturza D et al. Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-κB dependent pathway. Circulation 2007;116:1577-1584.
32. Lyss G, Knorre A, Schmidt TJ, Pahl HL, Merfort I. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-κB by directly targeting p65. J Biol Chem 1998;273:33508-33516.
33. Tirumurugaan KG, Jude JA, Kang BN, Panettieri RA, Walseth TF, Kannan MS. TNF-a induced CD38 expression in human airway smooth muscle cells: role of MAP kinases and transcription factors NF-κB and AP-1. Am J Physiol Lung Cell Mol Physiol 2007;292:L1385-L1395.
34. 2/cyclooxygenase-2 pathway. J Immunol 2007;179: 4821-4828.
35. 2 signaling pathway. J Biol Chem 2006;281: 24831-24846.
36. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695.
37. Erlinge D. Extracellular ATP: a central player in the regulation of vascular smooth muscle phenotype. Focus on 'Dual role of PKA in phenotype modulation of vascular smooth muscle cells by extracellular ATP'.Am J Physiol Cell Physiol 2004;287:C260-C262.
38. Hogarth DK, Sandbo N, Taurin S, Kolenko V, Miano JM, Dulin NO. Dual role of PKA in phenotypic modulation of vascular smooth muscle cells by extracellular ATP.Am J Physiol Cell Physiol 2004;287: C449-C456.
39. Hussain T, Gupta S, Adhami VM, Mukhtar H. Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int J Cancer 2005;113:660-669.
40. Lin FY, Chen YH, Tasi JS, Chen JW, Yang TL, Wang HJ et al. Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways. Arterioscler Thromb Vasc Biol 2006;26:2630- 2637.
41. Li C, Xu Q. Mechanical stress-initiated signal transductions in vascular smooth muscle cells. Cell Signal 2000;12:435-445.
42. LaPointe MC, Isenovic E. Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes. Hypertension 1999;33: 276-282.
43. Bezdecny SA, Karmaus P, Roth RA, Ganey PE. 2,2′,4,4′- Tetrachlorobiphenyl upregulates cyclooxygenase-2 in HL-60 cells via p38 mitogen-activated protein kinase and NF-κB. Toxicol Appl Pharmacol 2007;221:285-294.
44. Wei J, Yan W, Li X, Chang WC, Tai HH. Activation of thromboxane receptor alpha induces expression of cyclooxygenase-2 through multiple signaling pathways in A549 human lung adenocarcinoma cells. Biochem Pharmacol 2007;74:787-800.
45. Kumar A, Takada Y, Boriek AM, Aggarwal BB. Nuclear factor-κB: its role in health and disease. J Mol Med 2004;82:434-448.
46. Hsieh HL, Wang HH, Wu CY, Jou MJ, Yen MH, Parker P et al. BK-induced COX-2 expression via PKC-d-dependent activation of p42/p44 MAPK and NF-κB in astrocytes. Cell Signal 2007;19:330-340.
47. 2 by lipopolysaccharide in canine tracheal smooth muscle cells: involvement of MAPKs and NF-κB pathways. Cell Signal 2006;18:1201-1211.
48. Tzeng HP, Yang RS, Ueng TH, Liu SH. Upregulation of cyclooxygenase-2 by motorcycle exhaust particulate-induced reactive oxygen species enhances rat vascular smooth muscle cell proliferation. Chem Res Toxicol 2007;20:1170-1176.
49. 2 signaling pathways for human cholangiocarcinoma cell growth. J Biol Chem 2006;281:33982-33996.
50. 2 regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 b-treated human synovial fibroblasts. J Biol Chem 2001;276:31720-31731.
51. 2, and nonsteroidal anti-inflammatory drugs. Biochem Biophys Res Commun 2000;278:790-796.